Erlotinib for frontline treatment of advanced non–small cell lung cancer: a phase II study

G Giaccone, M Gallegos Ruiz, T Le Chevalier… - Clinical Cancer …, 2006 - AACR
Purpose: Erlotinib has proven activity in pretreated patients with advanced non–small cell
lung cancer (NSCLC). We evaluated erlotinib in the frontline treatment of advanced NSCLC …
被引用次数：274 相关文章

Erlotinib for Frontline Treatment of Advanced Non–Small Cell Lung Cancer: a Phase II Study

G Giaccone, MG Ruiz, T Le Chevalier… - Clinical Cancer …, 2006 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Purpose: Erlotinib has proven activity in
pretreated patients with advanced non–small cell lung cancer (NSCLC). We evaluated …

Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study.

G Giaccone, M Gallegos Ruiz, T Le Chevalier… - 2006 - christie.openrepository.com
PURPOSE: Erlotinib has proven activity in pretreated patients with advanced non-small cell
lung cancer (NSCLC). We evaluated erlotinib in the frontline treatment of advanced NSCLC …

Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study

G Giaccone, MG Ruiz… - … : an official journal …, 2006 - pubmed.ncbi.nlm.nih.gov
Purpose Erlotinib has proven activity in pretreated patients with advanced non-small cell
lung cancer (NSCLC). We evaluated erlotinib in the frontline treatment of advanced NSCLC …

[引用][C] Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study. Commentary

G GIACCONE, M GALLEGOS RUIZ… - Clinical cancer …, 2006 - pascal-francis.inist.fr
Erlotinib for frontline treatment of advanced non - small cell lung cancer : a phase II study.
Commentary CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study.

G Giaccone, T Le Chevalier, N Thatcher… - … Cancer Research: an …, 2006 - europepmc.org
Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

[引用][C] Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study. Commentary

G GIACCONE… - Clinical …, 2006 - American Association for Cancer …